Leishmaniasis impact and treatment access
- 1 October 2011
- journal article
- review article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 17 (10), 1471-1477
- https://doi.org/10.1111/j.1469-0691.2011.03635.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasisExpert Review of Anti-infective Therapy, 2010
- Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in IndiaThe New England Journal of Medicine, 2010
- Developments in the treatment of visceral leishmaniasisEmerging Drugs, 2009
- The Relationship between Leishmaniasis and AIDS: the Second 10 YearsClinical Microbiology Reviews, 2008
- Leishmaniasis and povertyTrends in Parasitology, 2006
- Leishmaniasis: current situation and new perspectivesComparative Immunology, Microbiology and Infectious Diseases, 2004
- VISCERAL LEISHMANIASIS: CONSEQUENCES OF A NEGLECTED DISEASE IN A BANGLADESHI COMMUNITYThe American Journal of Tropical Medicine and Hygiene, 2003
- The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: 'bringing down the neighbourhood'.Transactions of the Royal Society of Tropical Medicine and Hygiene, 2003
- Post-kala-azar dermal leishmaniasisThe Lancet Infectious Diseases, 2003
- Drug resistance in Indian visceral leishmaniasisTropical Medicine & International Health, 2001